|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2007-8-20
|
|
pubmed:abstractText |
Older node-positive patients treated with newer adjuvant chemotherapy regimens have improvements in relapse-free and overall survival similar to younger patients. We compared toxicity of older and younger patients in three randomized trials of adjuvant chemotherapy.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3699-704
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17704418-Age Factors,
pubmed-meshheading:17704418-Aged,
pubmed-meshheading:17704418-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17704418-Breast Neoplasms,
pubmed-meshheading:17704418-Chemotherapy, Adjuvant,
pubmed-meshheading:17704418-Cyclophosphamide,
pubmed-meshheading:17704418-Doxorubicin,
pubmed-meshheading:17704418-Female,
pubmed-meshheading:17704418-Humans,
pubmed-meshheading:17704418-Leukemia, Myeloid, Acute,
pubmed-meshheading:17704418-Lymphatic Metastasis,
pubmed-meshheading:17704418-Middle Aged,
pubmed-meshheading:17704418-Myelodysplastic Syndromes,
pubmed-meshheading:17704418-Neoplasms, Second Primary,
pubmed-meshheading:17704418-Paclitaxel
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
|
|
pubmed:affiliation |
University of Vermont, Vermont Cancer Center, Burlington, VT 05405, USA. hyman.muss@uvm.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|
